Skip to main content
. 2015 May 8;10(5):e0126672. doi: 10.1371/journal.pone.0126672

Table 1. Demographics and lifestyle characteristics of cases and controls of the Prostate Cancer Prevention Trial participants in the treatment arm (n = 1273).

Control (n = 676) Case (n = 597) p-value
Mean (SD)
Age (y) 63.8 (5.6) 64.1 (5.8) NA*
BMI (kg/m2) 27.7 (4.1) 27.5 (3.8) 0.54
Waist circumference, cm 102.0 (11.1) 101.8 (10.3) 0.72
Waist:hip ratio 1.0 (0.1) 1.0 (0.1) 0.54
Alcohol intake, g/d 9.1 (13.9) 10.1 (15.1) 0.23
Smoking, pack-years 14.9 (16.8) 14.3 (16.2) 0.58
Finasteride concentrations, ng/mL 30.05 (19.72) 29.35 (19.35) 0.53
n (%)
Diabetes 49 (7.2) 30 (5.0) 0.10
Family history of prostate cancer 147 (21.7) 135 (22.6) NA*
Race NA*
 White (Non-Hispanic) 503 (74.4) 556 (93.1)
 Black 91 (13.5) 27 (4.5)
 Other 82 (12.1) 14 (2.3)
BMI (kg/m2) 0.96
 Normal (<25) 181 (27.0) 156 (26.4)
 Overweight (25 to <30) 333 (49.6) 298 (50.3)
 Obese (> = 30) 157 (23.4) 138 (23.3)
Physical Activity 0.52
 Sedentary 130 (19.3) 117 (19.7)
 Light 263 (39.1) 249 (41.8)
 Moderate 213 (31.7) 183 (30.8)
 Active 66 (9.8) 46 (7.7)
Alcohol Intake 0.71
 Nondrinker 159 (23.5) 141 (23.6)
 <30 g/d 459 (67.9) 397 (66.5)
 > = 30 g/d 58 (8.6) 59 (9.9)
Smoking Status 0.21
 Never Smoker 237 (35.1) 204 (34.2)
 Current Smoker 57 (8.4) 36 (6.0)
 Past Smoker 382 (56.5) 357 (59.8)
Education 0.02
 High school or less 145 (21.5) 106 (17.8)
 Some college 210 (31.1) 161 (27.0)
 Graduate/professional school 320 (47.4) 330 (55.3)

* By study design, controls were frequency matched to cases based on age and family history, and oversampled to include all non-whites.